Danimer Q1 revenue $10.2M, loss continues; FY2024 EBITDA guidance at lower end of $(22)-$(32)M

Danimer Scientific, Inc.

2024-Q1 EPS reported -$0.26 revenue$10,224,000

Revenue $10.2M vs $11.9M YoY; PHA revenue up 64% ($3.2M), PLA down $4.3M from Ukraine conflict.
Adjusted EBITDA $(8.7)M vs $(8.9)M YoY; full-year guidance now 'closer to lower end' of $(22)-$(32)M.
Starbucks reapportioning Nodax straw business creates near-term Q2/Q3 headwinds; Danimer retains 100%.
First commercial order received for 20-million-pound cutlery award; $20M ABL facility closed April 19.
Proposed warrant dividend (1 per 3 shares) contingent on shareholder vote at July 9 annual meeting.

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Danimer Scientific, Inc. reported first quarter ended March 31, 2024 results: revenue $10.2 million. Guidance reaffirmed.

Period: first quarter ended March 31, 2024
Revenue: $10.2 million
Guidance: reaffirmed
Result: reported results

Exact text from the filing

new avenue to improve our balance sheet leverage, strengthen our capital structure and maximize stockholder value.” First Quarter 2024 Financial Highlights: • Revenues were $10.2 million in the first quarter of 2024 compared to revenue of $11.9 million in the first quarter of 2023. While PHA revenue increased by $3.2 million in the quarter as compared with the

View on SEC.gov

708 earnings releases filed in the last 30 days. Browse all earnings releases →

Source: SEC EDGAR

accession 0000950170-24-054457

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.